German researchers have found a peptide in human blood that blocks HIV and have identified a synthetic variant that is 100 times more potent, they reported Friday in the journal Cell.
New treatment yields complete regression of a human cancer in mice. A simple modification in an anti-cancer treatment currently in clinical trials substantially improves the drug’s effectiveness and reduces side effects in experiments.
Paralyzed lab rodents with spinal cord injuries apparently regained some ability to walk six weeks after a simple injection of biodegradable soap-like molecules that helped nerves regenerate. The research could have implications for humans with similar injuries.
A drug that offers the first real hope for around ten per cent of patients who suffer the common genetic disorders Duchenne Muscular Dystrophy and cystic fibrosis has been unveiled.
Beneficial effects are reported in studies on mice and the drug is now being tested on more than 100 patients, with initial data suggesting that it could offer the first treatment for the underlying disease.
Perhaps most remarkable of all is that the drug could also help a significant fraction of sufferers of around 2,000 other types of hereditary disease.
